Illumina, Inc.Illumina, Inc.Illumina, Inc.

Illumina, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪13.05 B‬EUR
6.73EUR
‪−1.18 B‬EUR
‪4.22 B‬EUR
‪149.43 M‬
Beta (1Y)
1.19
Employees (FY)
‪10.37 K‬
Change (1Y)
‪−1.64 K‬ −13.66%
Revenue / Employee (1Y)
‪407.26 K‬EUR
Net income / Employee (1Y)
‪−113.92 K‬EUR

About Illumina, Inc.


CEO
Jacob Thaysen
Headquarters
San Diego
Founded
1998
ISIN
US4523271090
FIGI
BBG000F2V0Z5
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Check out other big names from the same industry as ILU.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
ILMN5508412
Illumina, Inc. 5.75% 13-DEC-2027
Yield to maturity
Maturity date
Dec 13, 2027
ILMN5886317
Illumina, Inc. 4.65% 09-SEP-2026
Yield to maturity
Maturity date
Sep 9, 2026
ILMN5508411
Illumina, Inc. 5.8% 12-DEC-2025
Yield to maturity
Maturity date
Dec 12, 2025
ILMN5150650
Illumina, Inc. 2.55% 23-MAR-2031
Yield to maturity
Maturity date
Mar 23, 2031

See all ILU bonds 

Frequently Asked Questions


The current price of ILU is 83.79 EUR — it has increased by 2.42% in the past 24 hours. Watch Illumina, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange Illumina, Inc. stocks are traded under the ticker ILU.
ILU stock has fallen by −1.48% compared to the previous week, the month change is a −0.49% fall, over the last year Illumina, Inc. has showed a −27.59% decrease.
We've gathered analysts' opinions on Illumina, Inc. future price: according to them, ILU price has a max estimate of 158.36 EUR and a min estimate of 64.20 EUR. Watch ILU chart and read a more detailed Illumina, Inc. stock forecast: see what analysts think of Illumina, Inc. and suggest that you do with its stocks.
ILU reached its all-time high on Dec 18, 2008 with the price of 1,096,343.08 EUR, and its all-time low was 3.90 EUR and was reached on Jul 19, 2004. View more price dynamics on ILU chart.
See other stocks reaching their highest and lowest prices.
ILU stock is 2.37% volatile and has beta coefficient of 1.19. Track Illumina, Inc. stock price on the chart and check out the list of the most volatile stocks — is Illumina, Inc. there?
Today Illumina, Inc. has the market capitalization of ‪13.05 B‬, it has increased by 0.69% over the last week.
Yes, you can track Illumina, Inc. financials in yearly and quarterly reports right on TradingView.
Illumina, Inc. is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
ILU earnings for the last quarter are 1.01 EUR per share, whereas the estimation was 0.86 EUR resulting in a 17.59% surprise. The estimated earnings for the next quarter are 1.00 EUR per share. See more details about Illumina, Inc. earnings.
Illumina, Inc. revenue for the last quarter amounts to ‪898.99 M‬ EUR, despite the estimated figure of ‪892.05 M‬ EUR. In the next quarter, revenue is expected to reach ‪914.45 M‬ EUR.
ILU net income for the last quarter is ‪199.49 M‬ EUR, while the quarter before that showed ‪121.09 M‬ EUR of net income which accounts for 64.75% change. Track more Illumina, Inc. financial stats to get the full picture.
No, ILU doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 7, 2025, the company has ‪10.37 K‬ employees. See our rating of the largest employees — is Illumina, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Illumina, Inc. EBITDA is ‪1.22 B‬ EUR, and current EBITDA margin is 17.25%. See more stats in Illumina, Inc. financial statements.
Like other stocks, ILU shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Illumina, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Illumina, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Illumina, Inc. stock shows the sell signal. See more of Illumina, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.